Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970084893> ?p ?o ?g. }
- W1970084893 endingPage "2218" @default.
- W1970084893 startingPage "2211" @default.
- W1970084893 abstract "Objective Mizoribine (MZR) is an immunosuppressant that inhibits nucleic acid metabolism and is a relatively safe disease-modifying anti-rheumatic drug (DMARD). We evaluated the efficacy and safety of one single dose per day for patients with rheumatoid arthritis (RA). Patients and Methods In this study 32 patients with RA received MZR therapy. We evaluated the average dose of MZR and prednisolone, response to treatment and peak plasma level of MZR. Results The average dose of MZR was 146.1±31.2 (range: 50-200) mg/day. The average dose of prednisolone was 4.63±3.59 (range: 0-14) mg/day. The average plasma level of MZR, measured after 3 hours, was 2.20±0.49 μg/mL in the responder group and 1.59±0.82 μg/mL in the non-responder group (p=0.020). The treatment with MZR for 24 weeks was completed by 71.9% of patients and the proportion of patients who achieved a good and moderate response rate according to the European League Against Rheumatism (EULAR) criteria was 56.3% at 24 weeks. The plasma level of MZR which was greater than or equal to 2.12 μg/mL was significantly correlated with the clinical response (p<0.01). Only one of thirty-two cases discontinued the treatment, because of skin eruption. Conclusion This study included patients that could not be treated with other DMARDs and/or biologic agents because of age, interstitial pneumonia and other complications. We show that MZR may be a useful and relatively safe therapy for patients in this group." @default.
- W1970084893 created "2016-06-24" @default.
- W1970084893 creator A5000556430 @default.
- W1970084893 creator A5014932904 @default.
- W1970084893 creator A5015604127 @default.
- W1970084893 creator A5022076444 @default.
- W1970084893 creator A5030133069 @default.
- W1970084893 creator A5035694731 @default.
- W1970084893 creator A5035859888 @default.
- W1970084893 creator A5042469555 @default.
- W1970084893 creator A5044442302 @default.
- W1970084893 creator A5050158822 @default.
- W1970084893 creator A5070326257 @default.
- W1970084893 creator A5074758212 @default.
- W1970084893 creator A5084299259 @default.
- W1970084893 creator A5089657463 @default.
- W1970084893 creator A5091177614 @default.
- W1970084893 date "2010-01-01" @default.
- W1970084893 modified "2023-10-16" @default.
- W1970084893 title "Efficacy and Safety of Mizoribine by One Single Dose Administration for Patients with Rheumatoid Arthritis" @default.
- W1970084893 cites W1974557259 @default.
- W1970084893 cites W1998058209 @default.
- W1970084893 cites W2004026535 @default.
- W1970084893 cites W2021397728 @default.
- W1970084893 cites W2030262480 @default.
- W1970084893 cites W2037143192 @default.
- W1970084893 cites W2039266956 @default.
- W1970084893 cites W2042259969 @default.
- W1970084893 cites W2075102679 @default.
- W1970084893 cites W2088158803 @default.
- W1970084893 cites W2105845428 @default.
- W1970084893 cites W2107919679 @default.
- W1970084893 cites W2113652142 @default.
- W1970084893 cites W2123136435 @default.
- W1970084893 cites W2133132746 @default.
- W1970084893 cites W2149200961 @default.
- W1970084893 cites W2325125327 @default.
- W1970084893 cites W2330474549 @default.
- W1970084893 cites W2334921434 @default.
- W1970084893 doi "https://doi.org/10.2169/internalmedicine.49.3810" @default.
- W1970084893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20962439" @default.
- W1970084893 hasPublicationYear "2010" @default.
- W1970084893 type Work @default.
- W1970084893 sameAs 1970084893 @default.
- W1970084893 citedByCount "18" @default.
- W1970084893 countsByYear W19700848932012 @default.
- W1970084893 countsByYear W19700848932013 @default.
- W1970084893 countsByYear W19700848932014 @default.
- W1970084893 countsByYear W19700848932016 @default.
- W1970084893 countsByYear W19700848932017 @default.
- W1970084893 countsByYear W19700848932018 @default.
- W1970084893 countsByYear W19700848932019 @default.
- W1970084893 countsByYear W19700848932022 @default.
- W1970084893 crossrefType "journal-article" @default.
- W1970084893 hasAuthorship W1970084893A5000556430 @default.
- W1970084893 hasAuthorship W1970084893A5014932904 @default.
- W1970084893 hasAuthorship W1970084893A5015604127 @default.
- W1970084893 hasAuthorship W1970084893A5022076444 @default.
- W1970084893 hasAuthorship W1970084893A5030133069 @default.
- W1970084893 hasAuthorship W1970084893A5035694731 @default.
- W1970084893 hasAuthorship W1970084893A5035859888 @default.
- W1970084893 hasAuthorship W1970084893A5042469555 @default.
- W1970084893 hasAuthorship W1970084893A5044442302 @default.
- W1970084893 hasAuthorship W1970084893A5050158822 @default.
- W1970084893 hasAuthorship W1970084893A5070326257 @default.
- W1970084893 hasAuthorship W1970084893A5074758212 @default.
- W1970084893 hasAuthorship W1970084893A5084299259 @default.
- W1970084893 hasAuthorship W1970084893A5089657463 @default.
- W1970084893 hasAuthorship W1970084893A5091177614 @default.
- W1970084893 hasBestOaLocation W19700848931 @default.
- W1970084893 hasConcept C126322002 @default.
- W1970084893 hasConcept C2776715498 @default.
- W1970084893 hasConcept C2777489490 @default.
- W1970084893 hasConcept C2777575956 @default.
- W1970084893 hasConcept C2777882293 @default.
- W1970084893 hasConcept C2779123688 @default.
- W1970084893 hasConcept C2779134260 @default.
- W1970084893 hasConcept C3008058167 @default.
- W1970084893 hasConcept C524204448 @default.
- W1970084893 hasConcept C71924100 @default.
- W1970084893 hasConcept C90924648 @default.
- W1970084893 hasConceptScore W1970084893C126322002 @default.
- W1970084893 hasConceptScore W1970084893C2776715498 @default.
- W1970084893 hasConceptScore W1970084893C2777489490 @default.
- W1970084893 hasConceptScore W1970084893C2777575956 @default.
- W1970084893 hasConceptScore W1970084893C2777882293 @default.
- W1970084893 hasConceptScore W1970084893C2779123688 @default.
- W1970084893 hasConceptScore W1970084893C2779134260 @default.
- W1970084893 hasConceptScore W1970084893C3008058167 @default.
- W1970084893 hasConceptScore W1970084893C524204448 @default.
- W1970084893 hasConceptScore W1970084893C71924100 @default.
- W1970084893 hasConceptScore W1970084893C90924648 @default.
- W1970084893 hasIssue "20" @default.
- W1970084893 hasLocation W19700848931 @default.
- W1970084893 hasLocation W19700848932 @default.
- W1970084893 hasLocation W19700848933 @default.
- W1970084893 hasOpenAccess W1970084893 @default.
- W1970084893 hasPrimaryLocation W19700848931 @default.